Discover how our revolutionary vagus nerve stimulation technology harnesses cutting-edge neuroscience to enhance your well-being and performance.
The Reliwe uses non-invasive transcutaneous vagus nerve stimulation (tVNS) to gently activate the vagus nerve through the skin. This tenth cranial nerve is a key component of the parasympathetic nervous system, which controls your body's rest-and-digest response.
When stimulated, the vagus nerve sends signals to the brain that help regulate stress responses, inflammation, heart rate, and various other bodily functions. Our patented waveform technology delivers precise electrical pulses that mimic natural vagal tone, promoting balance and homeostasis throughout your body.
Position Reliwe on the neck, targeting the vagus nerve pathway.
Vagus nerve responds to stimulation, sending signals to the brain.
Body activates parasympathetic response, promoting relaxation and recovery.
Multiple clinical studies have demonstrated that vagus nerve stimulation can significantly reduce markers of stress and anxiety. Our 2023 study published in the Journal of Neuroscience showed a 47% reduction in cortisol levels after 4 weeks of daily use.
Research indicates that tVNS can improve heart rate variability, a key indicator of cardiovascular health and stress resilience. Users of Reliwe showed an average 23% improvement in HRV scores over 8 weeks.
Studies show that activating the parasympathetic nervous system before bed can significantly improve sleep onset and quality. Trial participants reported 35% better sleep quality scores and fell asleep 12 minutes faster on average.
The vagus nerve plays a crucial role in the inflammatory reflex. Research demonstrates that tVNS can help regulate inflammatory responses, with users showing reduced inflammatory markers (IL-6, TNF-α) after consistent use.
Emerging research suggests that vagus nerve stimulation may enhance focus, memory, and cognitive function. Preliminary studies show improved attention scores and working memory performance in regular users.